Search results (1345)
« Back to PublicationsFDG-avid nodal stage of oesophageal cancer and response to neoadjuvant chemotherapy: new classifications predicting disease progression before surgery, and early recurrence afterwards
Findlay JM. et al, (2015), BRITISH JOURNAL OF SURGERY, 102, 44 - 44
Off trial use of brentuximab vedotin in Hodgkin lymphoma - a regional experience
Browning JA. et al, (2015), BRITISH JOURNAL OF HAEMATOLOGY, 169, 61 - 61
Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer.
Bendell J. et al, (2015), Ann Oncol, 26, 804 - 811
Rare, fulminant presentations of anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma - a case series
Zhang XY. et al, (2015), BRITISH JOURNAL OF HAEMATOLOGY, 169, 56 - 56
The impact of oesophageal cancer temporal heterogeneity on DNA markers, drivers and targets, and the development of a combined clinical, genomic, pathological and radiological framework
Findlay JM. et al, (2015), BRITISH JOURNAL OF SURGERY, 102, 24 - 25
Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction.
Turkington RC. et al, (2015), J Clin Oncol, 33
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.
Chen J-L. et al, (2015), Int J Cancer, 136, E590 - E601
Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease
Dhalla F. et al, (2015), Journal of Clinical Immunology, 35, 112 - 118
O6.4VX-970, selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein.
Asmal M. et al, (2015), Ann Oncol, 26 Suppl 2
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.
Rizzuto I. et al, (2015), Int J Gynecol Cancer, 25, 416 - 422
Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.
Dhalla F. et al, (2015), J Clin Immunol, 35, 112 - 118
PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel.
Coupe N. et al, (2015), Eur J Cancer, 51, 359 - 366
Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation.
Hopkins TG. et al, (2015), Climacteric, 18, 94 - 98
Imaging tumour hypoxia with positron emission tomography.
Fleming IN. et al, (2015), Br J Cancer, 112, 238 - 250
A rare but potentially fatal cause of diarrhoea and weight loss: enteropathy-associated T-cell lymphoma.
Wali GN. et al, (2015), BMJ Case Rep, 2015
A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma
Collins GP. et al, (2015), British Journal of Haematology
Genomic Biomarkers of Oesophageal Cancer Survival and Response to Therapy
Findlay J. et al, (2015), BRITISH JOURNAL OF SURGERY, 102, 164 - 164
Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer.
Blagden SP., (2015), Front Oncol, 5
Management and controversies of classical Hodgkin lymphoma in pregnancy
Eyre TA. et al, (2015), British Journal of Haematology